Stock battle arena! At Bulios, we present the quality rating of individual shares through the <strong>Bulios Octagon Score (BOS)</strong>. This rating is the result of an analysis of several key metrics that we assess for each share within the industry and against similar companies. Just like in combat sports, shares are divided into weight categories according to their valuation to ensure the fairness of the rating within these metrics:
- EPS (Earnings per share) EPS (Earnings per share)
- P/E (Price/Earnings) P/E (Price/Earnings)
- Net Debt to EBITDA Net Debt to EBITDA
- ROIC (Return on invested capital) ROIC (Return on invested capital)
- ROA (Return on assets) ROA (Return on assets)
- ROE (Return on equity) ROE (Return on equity)
- DE (Debt/Equity ratio) DE (Debt/Equity ratio)
- Beta Beta
Each of these metrics represents a key aspect of assessing the quality of a stock from different angles. Our visualisation will give you a quick overview of the investment potential of each stock and make it easier for you to decide whether to investigate further.
Souhlasím s tebou a vidím je taky stále jako lídry na trhu, $ENPH+7.2% myslím. Sám tam mam pozici už větší a pod 100$ bych přikupoval. Je to ale běh na delší trať ještě. V USA jak si psal, ta poptávka teď klesla, ale snad na konci roku či přes rok jak by mohli padat úrokové sazby se zase poptávka zvýší, plus přesně jak píšeš, snaží se inovovat, přicházet s novými technologiemi a expandovat. O $VALE+0.0% uvažuji, kdyby se dostala někam kolem 10$, nakupuji hned. 😁